On the public citation graph

Immunosuppressive mechanisms in glioblastoma: Fig. 1.

0 signed · 442 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/ijc.21544openalex-snapshot

Immune stimulatory effects of CD70 override CD70‐mediated immune cell apoptosis in rodent glioma models and confer long‐lasting antiglioma immunity in vivo

inferredcites →https://doi.org/10.1002/ijc.28426openalex-snapshot

Glioma‐derived galectin‐1 regulates innate and adaptive antitumor immunity

inferredcites →https://doi.org/10.1002/ijc.29309openalex-snapshot

Enhanced immunosuppression by therapy‐exposed glioblastoma multiforme tumor cells

inferredcites →https://doi.org/10.1002/j.1460-2075.1987.tb02411.xopenalex-snapshot

T cell suppressor factor from human glioblastoma cells is a 12.5‐kd protein closely related to transforming growth factor‐beta.

inferredcites →https://doi.org/10.1002/j.1460-2075.1987.tb02700.xopenalex-snapshot

Complementary DNA for human glioblastoma‐derived T cell suppressor factor, a novel member of the transforming growth factor‐beta gene family.

inferredcites →https://doi.org/10.1002/path.2370openalex-snapshot

Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas

inferredcites →https://doi.org/10.1006/cimm.2000.1625openalex-snapshot

Nitric-Oxide-Dependent Systemic Immunosuppression in Animals with Progressively Growing Malignant Gliomas

inferredcites →https://doi.org/10.1007/bf02815350openalex-snapshot

Colony stimulating factor-1 expression in human glioma

inferredcites →https://doi.org/10.1007/s00262-007-0336-xopenalex-snapshot

Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy

inferredcites →https://doi.org/10.1007/s11060-011-0786-zopenalex-snapshot

Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway

inferredcites →https://doi.org/10.1016/0006-8993(94)91055-3openalex-snapshot

Selective expression of interleukin-10 gene within glioblastoma multiforme

inferredcites →https://doi.org/10.1016/j.ijrobp.2012.12.025openalex-snapshot

Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas

inferredcites →https://doi.org/10.1016/j.immuni.2007.05.016openalex-snapshot

Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell Responses

inferredcites →https://doi.org/10.1016/j.jneuroim.2010.04.003openalex-snapshot

Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions

inferredcites →https://doi.org/10.1016/s0140-6736(14)60958-2openalex-snapshot

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

inferredcites →https://doi.org/10.1016/s0165-5728(01)00361-7openalex-snapshot

Expression of Fas ligand by microglia: possible role in glioma immune evasion

inferredcites →https://doi.org/10.1016/s1074-7613(00)80366-0openalex-snapshot

The Emerging Role of CTLA-4 as an Immune Attenuator

inferredcites →https://doi.org/10.1038/359843a0openalex-snapshot

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

inferredcites →https://doi.org/10.1038/ni.1818openalex-snapshot

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

inferredcites →https://doi.org/10.1038/nm.3337openalex-snapshot

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

inferredcites →https://doi.org/10.1038/nm1096-1096openalex-snapshot

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

inferredcites →https://doi.org/10.1038/nm1517openalex-snapshot

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

inferredcites →https://doi.org/10.1038/nm730openalex-snapshot

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

inferredcites →https://doi.org/10.1038/nm934openalex-snapshot

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

inferredcites →https://doi.org/10.1038/nri978openalex-snapshot

Alternative activation of macrophages

inferredcites →https://doi.org/10.1056/nejmoa1003466openalex-snapshot

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

inferredcites →https://doi.org/10.1056/nejmoa1104621openalex-snapshot

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

inferredcites →https://doi.org/10.1056/nejmoa1305133openalex-snapshot

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

inferredcites →https://doi.org/10.1084/jem.192.2.303openalex-snapshot

Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4

inferredcites →https://doi.org/10.1084/jem.20112738openalex-snapshot

Cancer immunoediting by the innate immune system in the absence of adaptive immunity

inferredcites →https://doi.org/10.1084/jem.20130678openalex-snapshot

Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection

inferredcites →https://doi.org/10.1091/mbc.4.1.121openalex-snapshot

Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology.

inferredcites →https://doi.org/10.1093/emboj/17.4.1006openalex-snapshot

IL‐10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3‐dependent and ‐independent pathways

inferredcites →https://doi.org/10.1093/jnci/dju162openalex-snapshot

Effect of miR-142-3p on the M2 Macrophage and Therapeutic Efficacy Against Murine Glioblastoma

inferredcites →https://doi.org/10.1093/jnci/djv137openalex-snapshot

FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas

inferredcites →https://doi.org/10.1093/neuonc/nop023openalex-snapshot

Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties

inferredcites →https://doi.org/10.1093/neuonc/noq082openalex-snapshot

Glioma cancer stem cells induce immunosuppressive macrophages/microglia

inferredcites →https://doi.org/10.1093/neuonc/noq142openalex-snapshot

Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

inferredcites →https://doi.org/10.1093/neuonc/nor134openalex-snapshot

Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors

inferredcites →https://doi.org/10.1093/neuonc/nos014openalex-snapshot

Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy

inferredcites →https://doi.org/10.1093/neuonc/nou046openalex-snapshot

JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma

inferredcites →https://doi.org/10.1093/neuonc/nou307openalex-snapshot

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

inferredcites →https://doi.org/10.1097/00006123-200004000-00035openalex-snapshot

Flow Cytometric Characterization of Tumor-associated Macrophages in Experimental Gliomas

inferredcites →https://doi.org/10.1097/nen.0000000000000183openalex-snapshot

Increase in Both CD14-Positive and CD15-Positive Myeloid-Derived Suppressor Cell Subpopulations in the Blood of Patients With Glioma But Predominance of CD15-Positive Myeloid-Derived Suppressor Cells in Glioma Tissue

inferredcites →https://doi.org/10.1097/ppo.0b013e3182452e0dopenalex-snapshot

Glioblastoma Cancer Stem-Like Cells

inferredcites →https://doi.org/10.1111/j.1750-3639.2009.00315.xopenalex-snapshot

Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments

inferredcites →https://doi.org/10.1158/0008-5472.can-04-4395openalex-snapshot

Glioblastomas Induce T-Lymphocyte Death by Two Distinct Pathways Involving Gangliosides and CD70

inferredcites →https://doi.org/10.1158/0008-5472.can-05-3062openalex-snapshot

Regeneration and Tolerance Factor: A Novel Mediator of Glioblastoma-Associated Immunosuppression

inferredcites →https://doi.org/10.1158/0008-5472.can-05-3773openalex-snapshot

Increased Regulatory T-Cell Fraction Amidst a Diminished CD4 Compartment Explains Cellular Immune Defects in Patients with Malignant Glioma

inferredcites →https://doi.org/10.1158/0008-5472.can-06-4783openalex-snapshot

Malignant Glioma Cells Counteract Antitumor Immune Responses through Expression of Lectin-Like Transcript-1

inferredcites →https://doi.org/10.1158/0008-5472.can-07-1243openalex-snapshot

A Novel Small Molecule Inhibitor of Signal Transducers and Activators of Transcription 3 Reverses Immune Tolerance in Malignant Glioma Patients

inferredcites →https://doi.org/10.1158/0008-5472.can-12-4124openalex-snapshot

GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α

inferredcites →https://doi.org/10.1158/0008-5472.can-12-4318openalex-snapshot

miR-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of Glioma

inferredcites →https://doi.org/10.1158/1078-0432.ccr-06-2070openalex-snapshot

Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function

inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-0320openalex-snapshot

Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas

inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-1329openalex-snapshot

The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas

inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-1067openalex-snapshot

Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines

inferredcites →https://doi.org/10.1158/1078-0432.ccr-11-1107openalex-snapshot

Neutrophil Degranulation and Immunosuppression in Patients with GBM: Restoration of Cellular Immune Function by Targeting Arginase I

inferredcites →https://doi.org/10.1158/1078-0432.ccr-12-3314openalex-snapshot

Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages

inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-0514openalex-snapshot

Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors

inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-1380openalex-snapshot

First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma

inferredcites →https://doi.org/10.1158/1535-7163.mct-09-0734openalex-snapshot

Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway

inferredcites →https://doi.org/10.1158/1535-7163.mct-11-0801openalex-snapshot

STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression

inferredcites →https://doi.org/10.1158/1541-7786.mcr-12-0528openalex-snapshot

Activation of the NF-κB Pathway by the STAT3 Inhibitor JSI-124 in Human Glioblastoma Cells

inferredcites →https://doi.org/10.1158/2326-6066.cir-13-0028openalex-snapshot

Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas

inferredcites →https://doi.org/10.1159/000154883openalex-snapshot

CD95-Dependent T-Cell Killing by Glioma Cells Expressing CD95 Ligand: More on Tumor Immune Escape, the CD95 Counterattack, and the Immune Privilege of the Brain

inferredcites →https://doi.org/10.1159/000453569openalex-snapshot

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

inferredcites →https://doi.org/10.1159/000455014openalex-snapshot

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review

inferredcites →https://doi.org/10.1200/jco.2013.53.0105openalex-snapshot

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

inferredcites →https://doi.org/10.1227/00006123-199512000-00016openalex-snapshot

Human Glioma-derived Interleukin-10 Inhibits Antitumor Immune Responses In Vitro

inferredcites →https://doi.org/10.1371/journal.pone.0016195openalex-snapshot

Hypoxia Potentiates Glioma-Mediated Immunosuppression

inferredcites →https://doi.org/10.1371/journal.pone.0018820openalex-snapshot

The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells

inferredcites →https://doi.org/10.1371/journal.pone.0031046openalex-snapshot

A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma

inferredcites →https://doi.org/10.1371/journal.pone.0084723openalex-snapshot

Inhibition of STAT3 Reduces Astrocytoma Cell Invasion and Constitutive Activation of STAT3 Predicts Poor Prognosis in Human Astrocytoma

inferredcites →https://doi.org/10.1523/jneurosci.5812-12.2013openalex-snapshot

PD-L1 Expression by Neurons Nearby Tumors Indicates Better Prognosis in Glioblastoma Patients

inferredcites →https://doi.org/10.18632/oncotarget.3467openalex-snapshot

Transforming growth factor-β pathway activity in glioblastoma

inferredcites →https://doi.org/10.18632/oncotarget.663openalex-snapshot

Modulating Antiangiogenic Resistance by Inhibiting the Signal Transducer and Activator of Transcription 3 Pathway in Glioblastoma

inferredcites →https://doi.org/10.3171/2009.11.jns09901openalex-snapshot

Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma

inferredcites →https://doi.org/10.3171/jns.1983.59.5.0790openalex-snapshot

Presence of immunosuppressive factors in brain-tumor cyst fluid

inferredcites →https://doi.org/10.3171/jns.1990.72.4.0619openalex-snapshot

Influence of PGE2- and cAMP-modulating agents on human glioblastoma cell killing by interleukin-2-activated lymphocytes

inferredcites →https://doi.org/10.3892/ijo.2014.2439openalex-snapshot

Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line

inferredcites →https://doi.org/10.4049/jimmunol.1103248openalex-snapshot

Tumor-Associated Microglia/Macrophages Enhance the Invasion of Glioma Stem-like Cells via TGF-β1 Signaling Pathway

inferredcites →https://doi.org/10.4049/jimmunol.132.4.1837openalex-snapshot

Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

inferredcites →https://doi.org/10.4049/jimmunol.166.1.678openalex-snapshot

Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer

inferredcites →https://doi.org/10.4049/jimmunol.180.4.2089openalex-snapshot

Inhibition of STAT3 Promotes the Efficacy of Adoptive Transfer Therapy Using Type-1 CTLs by Modulation of the Immunological Microenvironment in a Murine Intracranial Glioma

inferredcites →https://doi.org/10.4049/jimmunol.181.8.5791openalex-snapshot

Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4479326openalex-extracted

inferred← citeshttps://doi.org/10.1002/1878-0261.70095openalex-snapshot

Pericytes change function depending on glioblastoma vicinity: emphasis on immune regulation

inferred← citeshttps://doi.org/10.1002/adfm.202412040openalex-snapshot

Autologous Nanovaccine Induces Immunogenic Domino Effect to Prevent Postoperative Recurrence of Orthotopic Glioblastoma

inferred← citeshttps://doi.org/10.1002/adtp.202000109openalex-snapshot

Deep Tissue Translocation of Graphene Oxide Sheets in Human Glioblastoma 3D Spheroids and an Orthotopic Xenograft Model

inferred← citeshttps://doi.org/10.1002/adtp.202400374openalex-snapshot

Targeting VEGF‐A in an Immunocompetent Orthotopic Mouse Model of Mesenchymal Glioblastoma Improves Antitumorigenicity and Decreases Proinflammatory Response in Normal Brain Tissue after Fractionated Radiotherapy

inferred← citeshttps://doi.org/10.1002/btm2.10716openalex-snapshot

Advances in bioengineered CAR T/ NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/ NK cell therapy

inferred← citeshttps://doi.org/10.1002/btm2.70018openalex-snapshot

Cell therapies against brain tumors: Clinical development and emerging prospects

inferred← citeshttps://doi.org/10.1002/cam4.2767openalex-snapshot

Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma

inferred← citeshttps://doi.org/10.1002/cnr2.1220openalex-snapshot

Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools

inferred← citeshttps://doi.org/10.1002/ctd2.70133openalex-snapshot

Sex differences in genomics, immune microenvironment and immunotherapy response in adult grade 4 gliomas

inferred← citeshttps://doi.org/10.1002/ijc.31661openalex-snapshot

Expression of LAG‐3 and efficacy of combination treatment with anti‐LAG‐3 and anti‐PD‐1 monoclonal antibodies in glioblastoma

inferred← citeshttps://doi.org/10.1002/jcp.25874openalex-snapshot

T11TS repress gliomagenic apoptosis of bone marrow hematopoietic stem cells

inferred← citeshttps://doi.org/10.1002/jcp.28197openalex-snapshot

Overexpression of oncostatin M receptor regulates local immune response in glioblastoma

inferred← citeshttps://doi.org/10.1002/jev2.70355openalex-snapshot

NF1 Leucine Rich Domain‐Derived Extracellular Vesicles Remodel the Glioblastoma Immune Microenvironment via an ADAM17‐Associated Inflammatory Program

inferred← citeshttps://doi.org/10.1002/pbc.26158openalex-snapshot

Preoperative systemic levels of VEGFA, IL‐7, IL‐17A, and TNF‐β delineate two distinct groups of children with brain tumors

inferred← citeshttps://doi.org/10.1002/smtd.202100197openalex-snapshot

An In Silico Glioblastoma Microenvironment Model Dissects the Immunological Mechanisms of Resistance to PD‐1 Checkpoint Blockade Immunotherapy

inferred← citeshttps://doi.org/10.1007/16833_2022_71openalex-snapshot

Immunotherapeutic Strategies for Glioma Treatment

inferred← citeshttps://doi.org/10.1007/978-3-030-16908-4_2openalex-snapshot

Pericytes in Glioblastomas: Multifaceted Role Within Tumor Microenvironments and Potential for Therapeutic Interventions

inferred← citeshttps://doi.org/10.1007/978-3-030-27359-0_16openalex-snapshot

Immunotherapy and Gliomas

inferred← citeshttps://doi.org/10.1007/978-3-030-41008-7_8openalex-snapshot

Immunotherapy for Neuro-Oncology

inferred← citeshttps://doi.org/10.1007/978-3-030-79308-1_7openalex-snapshot

Immunotherapy for Neuro-oncology

inferred← citeshttps://doi.org/10.1007/978-3-031-14732-6_4openalex-snapshot

The Role of Cellular Immunity and Adaptive Immunity in Pathophysiology of Brain and Spinal Cord Tumors

inferred← citeshttps://doi.org/10.1007/978-3-319-95684-8_2openalex-snapshot

Basics of Brain Tumor Biology for Clinicians

inferred← citeshttps://doi.org/10.1007/s00262-018-2214-0openalex-snapshot

High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with Treg depletion

inferred← citeshttps://doi.org/10.1007/s00262-022-03358-3openalex-snapshot

Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy

inferred← citeshttps://doi.org/10.1007/s00262-024-03837-9openalex-snapshot

PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis

inferred← citeshttps://doi.org/10.1007/s00281-016-0616-7openalex-snapshot

The development of dendritic cell vaccine-based immunotherapies for glioblastoma

inferred← citeshttps://doi.org/10.1007/s00432-021-03762-9openalex-snapshot

Regulation of prognosis-related Siglecs in the glioma microenvironment

inferred← citeshttps://doi.org/10.1007/s10014-016-0259-3openalex-snapshot

MicroRNA and extracellular vesicles in glioblastoma: small but powerful

inferred← citeshttps://doi.org/10.1007/s10147-025-02777-3openalex-snapshot

The curse of blood–brain barrier and blood–tumor barrier in malignant brain tumor treatment

inferred← citeshttps://doi.org/10.1007/s10555-024-10183-wopenalex-snapshot

Glioblastoma stem cell metabolism and immunity

inferred← citeshttps://doi.org/10.1007/s10637-019-00788-2openalex-snapshot

Pam3CSK4, a TLR2 ligand, induces differentiation of glioblastoma stem cells and confers susceptibility to temozolomide

inferred← citeshttps://doi.org/10.1007/s11060-016-2319-2openalex-snapshot

Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma

inferred← citeshttps://doi.org/10.1007/s11060-019-03193-0openalex-snapshot

Triptolide reverses helper T cell inhibition and down-regulates IFN-γ induced PD-L1 expression in glioma cell lines

inferred← citeshttps://doi.org/10.1007/s11060-020-03598-2openalex-snapshot

Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor

inferred← citeshttps://doi.org/10.1007/s11060-020-03684-5openalex-snapshot

Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies

inferred← citeshttps://doi.org/10.1007/s11060-022-04047-yopenalex-snapshot

Pre-surgery immune profiles of adult glioma patients

inferred← citeshttps://doi.org/10.1007/s11060-023-04257-yopenalex-snapshot

T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma

inferred← citeshttps://doi.org/10.1007/s11060-024-04647-wopenalex-snapshot

Results from a first-in-human phase I safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma

inferred← citeshttps://doi.org/10.1007/s11060-024-04798-wopenalex-snapshot

Dendritic cell vaccine for glioblastoma: an updated meta-analysis and trial sequential analysis

inferred← citeshttps://doi.org/10.1007/s11060-025-04978-2openalex-snapshot

Improving IL12 immunotherapy in glioblastoma by targeting the long noncoding RNA INCR1

inferred← citeshttps://doi.org/10.1007/s11060-025-04989-zopenalex-snapshot

Tumor-infiltrating and circulating B cells mediate local and systemic immunomodulatory mechanisms in Glioblastoma

inferred← citeshttps://doi.org/10.1007/s11302-020-09705-2openalex-snapshot

P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas

inferred← citeshttps://doi.org/10.1007/s11523-019-00655-3openalex-snapshot

The Role of Checkpoint Inhibitors in Glioblastoma

inferred← citeshttps://doi.org/10.1007/s11864-020-00773-5openalex-snapshot

Tumor Treating Fields in the Management of Patients with Malignant Gliomas

inferred← citeshttps://doi.org/10.1007/s11910-017-0754-xopenalex-snapshot

The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma–Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses

inferred← citeshttps://doi.org/10.1007/s11910-020-01042-6openalex-snapshot

Novel Therapies for Glioblastoma

inferred← citeshttps://doi.org/10.1007/s11912-020-01007-5openalex-snapshot

Current Advances in Immunotherapy for Glioblastoma

inferred← citeshttps://doi.org/10.1007/s12672-024-01653-2openalex-snapshot

Identification of critical biomarkers and immune landscape patterns in glioma based on multi-database

inferred← citeshttps://doi.org/10.1007/s12672-025-04052-3openalex-snapshot

A signature constructed with circadian rhythm-related genes to predict the prognosis and therapy response for low-grade gliomas

inferred← citeshttps://doi.org/10.1007/s13311-022-01251-6openalex-snapshot

Updates in IDH-Wildtype Glioblastoma

inferred← citeshttps://doi.org/10.1007/s40263-017-0456-6openalex-snapshot

EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise

inferred← citeshttps://doi.org/10.1007/s43152-020-00016-7openalex-snapshot

The Effect of Glioblastoma on Pericytes

inferred← citeshttps://doi.org/10.1016/b978-0-12-819609-0.00003-1openalex-snapshot

Autophagy in brain tumor immune evasion and responses to immunotherapy

inferred← citeshttps://doi.org/10.1016/b978-0-12-821567-8.00008-7openalex-snapshot

Glioblastoma cell-induced immunosuppression causing chemoresistance

inferred← citeshttps://doi.org/10.1016/b978-0-12-821567-8.00020-8openalex-snapshot

Overview of glioblastoma biological hallmarks and molecular pathology

inferred← citeshttps://doi.org/10.1016/b978-0-323-90509-1.00026-6openalex-snapshot

Phase zero clinical trials

inferred← citeshttps://doi.org/10.1016/b978-0-323-99873-4.00012-8openalex-snapshot

Optimizing the role of immunotherapy for the treatment of glioblastoma

inferred← citeshttps://doi.org/10.1016/b978-0-443-33319-4.00010-0openalex-snapshot

Peptide-anchored nanocarrier(s) therapy for glioblastoma

inferred← citeshttps://doi.org/10.1016/b978-0-443-33382-8.00011-xopenalex-snapshot

Lipid-drug conjugates for the treatment of glioblastomas

inferred← citeshttps://doi.org/10.1016/j.actbio.2019.01.020openalex-snapshot

Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy

inferred← citeshttps://doi.org/10.1016/j.actbio.2023.10.022openalex-snapshot

Implantable SDF-1α-loaded silk fibroin hyaluronic acid aerogel sponges as an instructive component of the glioblastoma ecosystem: Between chemoattraction and tumor shaping into resection cavities

inferred← citeshttps://doi.org/10.1016/j.addr.2017.06.006openalex-snapshot

Engineering challenges for brain tumor immunotherapy

inferred← citeshttps://doi.org/10.1016/j.addr.2021.01.012openalex-snapshot

Frontiers in the treatment of glioblastoma: Past, present and emerging

inferred← citeshttps://doi.org/10.1016/j.addr.2022.114367openalex-snapshot

Opportunities for improving brain cancer treatment outcomes through imaging-based mathematical modeling of the delivery of radiotherapy and immunotherapy

inferred← citeshttps://doi.org/10.1016/j.bioactmat.2023.04.021openalex-snapshot

Nanomaterials with dual immunomodulatory functions for synergistic therapy of breast cancer brain metastases

inferred← citeshttps://doi.org/10.1016/j.bioactmat.2023.08.022openalex-snapshot

Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy

inferred← citeshttps://doi.org/10.1016/j.biomaterials.2018.07.035openalex-snapshot

Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma

inferred← citeshttps://doi.org/10.1016/j.biopha.2023.116113openalex-snapshot

Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment

inferred← citeshttps://doi.org/10.1016/j.canlet.2020.09.028openalex-snapshot

Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy

inferred← citeshttps://doi.org/10.1016/j.canlet.2023.216169openalex-snapshot

Radiation combined with oncolytic vaccinia virus provides pronounced antitumor efficacy and induces immune protection in an aggressive glioblastoma model

inferred← citeshttps://doi.org/10.1016/j.canlet.2025.217928openalex-snapshot

Neuroimmunology-driven CAR T-cell therapeutics for gliomas: translational challenges and clinical trial paradigm innovation

inferred← citeshttps://doi.org/10.1016/j.cbi.2019.108816openalex-snapshot

Modulation of glioma-inflammation crosstalk profiles in human glioblastoma cells by indirubin-3’-(2,3 dihydroxypropyl)-oximether (E804) and 7-bromoindirubin-3′-oxime (7BIO)

inferred← citeshttps://doi.org/10.1016/j.ccell.2022.12.007openalex-snapshot

MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors

inferred← citeshttps://doi.org/10.1016/j.cej.2026.176873openalex-snapshot

Heterodimeric prodrug nanoassembly overcomes chemoresistance and ignites immunotherapy in glioblastoma

inferred← citeshttps://doi.org/10.1016/j.celbio.2025.100016openalex-snapshot

Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies

inferred← citeshttps://doi.org/10.1016/j.clim.2021.108719openalex-snapshot

Integrated analysis of the genomic and transcriptional profile of high-grade gliomas in different age groups

inferred← citeshttps://doi.org/10.1016/j.clim.2026.110731openalex-snapshot

Comparison between glioblastoma and brain metastases: How epigenetic remodeling can enhance immunotherapy

inferred← citeshttps://doi.org/10.1016/j.ctrv.2018.06.016openalex-snapshot

Checkpoint inhibitors as treatment for malignant gliomas: “A long way to the top”

inferred← citeshttps://doi.org/10.1016/j.ejps.2021.106044openalex-snapshot

Reversing tumor immunosuppressive microenvironment via targeting codelivery of CpG ODNs/PD-L1 peptide antagonists to enhance the immune checkpoint blockade-based anti-tumor effect

inferred← citeshttps://doi.org/10.1016/j.esmoop.2026.106902openalex-snapshot

Molecular immune signature identifies microglia and NK cell infiltration as a favorable prognostic marker in adult-type high-grade glioma

inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e20178openalex-snapshot

Novel immune checkpoint-related gene model to predict prognosis and treatment responsiveness in low-grade gliomas

inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e30494openalex-snapshot

The gut-brain-axis: A positive relationship between gut microbial dysbiosis and glioblastoma brain tumour

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2020.119865openalex-snapshot

Application prospect of peptide-modified nano targeting drug delivery system combined with PD-1/PD-L1 based immune checkpoint blockade in glioblastoma

inferred← citeshttps://doi.org/10.1016/j.immuni.2025.03.021openalex-snapshot

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies

inferred← citeshttps://doi.org/10.1016/j.intimp.2024.113048openalex-snapshot

The potential of mesenchymal stem cell coexpressing cytosine deaminase and secretory IL18-FC chimeric cytokine in suppressing glioblastoma recurrence

inferred← citeshttps://doi.org/10.1016/j.jconrel.2020.01.005openalex-snapshot

Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma

inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.114454openalex-snapshot

Breaking barriers in immunotherapy: harnessing ultrasound for enhanced drug delivery and immune activation

inferred← citeshttps://doi.org/10.1016/j.jneumeth.2019.108484openalex-snapshot

Companion animal models of neurological disease

inferred← citeshttps://doi.org/10.1016/j.jneuroim.2019.04.010openalex-snapshot

The role of microglia and P2X7 receptors in gliomas

inferred← citeshttps://doi.org/10.1016/j.mam.2017.12.003openalex-snapshot

Role of extracellular vesicles in glioma progression

inferred← citeshttps://doi.org/10.1016/j.molmed.2021.12.008openalex-snapshot

NK cells in the brain: implications for brain tumor development and therapy

inferred← citeshttps://doi.org/10.1016/j.molonc.2016.05.005openalex-snapshot

Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients

inferred← citeshttps://doi.org/10.1016/j.nantod.2026.103061openalex-snapshot

BBB-penetrating biomimetic nanoparticles orchestrate STING activation and metabolic immunomodulation for potent glioma immunotherapy

inferred← citeshttps://doi.org/10.1016/j.nec.2020.12.004openalex-snapshot

Therapeutic Delivery to Central Nervous System

inferred← citeshttps://doi.org/10.1016/j.nec.2021.01.003openalex-snapshot

Brain Tumor Vaccines

inferred← citeshttps://doi.org/10.1016/j.neuint.2021.105049openalex-snapshot

Bioscaffold-based study of glioblastoma cell behavior and drug delivery for tumor therapy

inferred← citeshttps://doi.org/10.1016/j.neuron.2022.10.027openalex-snapshot

Interfer(on)ing with Zika virus

inferred← citeshttps://doi.org/10.1016/j.omtm.2022.10.010openalex-snapshot

Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β

inferred← citeshttps://doi.org/10.1016/j.omto.2021.07.009openalex-snapshot

Treatment of glioblastoma with current oHSV variants reveals differences in efficacy and immune cell recruitment

inferred← citeshttps://doi.org/10.1016/j.omton.2025.201030openalex-snapshot

An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma

inferred← citeshttps://doi.org/10.1016/j.omton.2026.201134openalex-snapshot

A comparative analysis of CD70-directed CAR-T cells for glioblastoma treatment demonstrates a superior efficacy of the ligand-based construct

inferred← citeshttps://doi.org/10.1016/j.smim.2020.101385openalex-snapshot

Tumor antigens in glioma

inferred← citeshttps://doi.org/10.1016/j.stem.2017.03.018openalex-snapshot

TLRgeting Evasion of Immune Pathways in Glioblastoma

inferred← citeshttps://doi.org/10.1016/j.trecan.2019.02.008openalex-snapshot

The Gut–Brain Axis, Paving the Way to Brain Cancer

inferred← citeshttps://doi.org/10.1016/j.trsl.2024.06.001openalex-snapshot

A proteomic approach supports the clinical relevance of TAT-Cx43266-283 in glioblastoma

inferred← citeshttps://doi.org/10.1016/j.wneu.2016.08.063openalex-snapshot

Defining the Immune Phenotype for Glioblastoma Multiforme: One Step Closer to Understanding Our Enemy

inferred← citeshttps://doi.org/10.1016/j.wneu.2018.05.239openalex-snapshot

Emerging Strategies and Future Perspective in Neuro-Oncology Using Transcranial Focused Ultrasonography Technology

inferred← citeshttps://doi.org/10.1016/j.wneu.2018.12.222openalex-snapshot

Immunotherapy for High-Grade Gliomas: A Clinical Update and Practical Considerations for Neurosurgeons

inferred← citeshttps://doi.org/10.1016/j.wneu.2019.05.205openalex-snapshot

Current Approaches and Challenges in the Molecular Therapeutic Targeting of Glioblastoma

inferred← citeshttps://doi.org/10.1016/j.xcrm.2025.102258openalex-snapshot

BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastoma

inferred← citeshttps://doi.org/10.1016/j.ymthe.2023.08.009openalex-snapshot

Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L: Translational developments from rodents to glioma patients

inferred← citeshttps://doi.org/10.1016/s0007-4551(18)30391-6openalex-snapshot

Immunothérapie des glioblastomes

inferred← citeshttps://doi.org/10.1021/acs.nanolett.9b03968openalex-snapshot

Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined with Anti-PD-L1 Antibody for Improved Glioma Treatment

inferred← citeshttps://doi.org/10.1021/acsabm.5c00209openalex-snapshot

Engineered Flagellin Biomaterial as a Pattern Recognition Receptor Signal Activating Immunostimulants and Controlled Release of Boronated Anti-Cancer Drugs

inferred← citeshttps://doi.org/10.1021/acschembio.0c00078openalex-snapshot

Phenotypic Screening of Chemical Libraries Enriched by Molecular Docking to Multiple Targets Selected from Glioblastoma Genomic Data

inferred← citeshttps://doi.org/10.1021/acsnano.3c01215openalex-snapshot

Multifunctional Calcium–Manganese Nanomodulator Provides Antitumor Treatment and Improved Immunotherapy via Reprogramming of the Tumor Microenvironment

inferred← citeshttps://doi.org/10.1021/acsnano.8b06842openalex-snapshot

High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme

inferred← citeshttps://doi.org/10.1038/nrclinonc.2016.204openalex-snapshot

Advances in the molecular genetics of gliomas — implications for classification and therapy

inferred← citeshttps://doi.org/10.1038/nrneurol.2017.64openalex-snapshot

Vaccine-based immunotherapeutic approaches to gliomas and beyond

inferred← citeshttps://doi.org/10.1038/s41388-018-0261-9openalex-snapshot

Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways

inferred← citeshttps://doi.org/10.1038/s41419-023-06255-4openalex-snapshot

Schnurri-3 drives tumor growth and invasion in cancer cells expressing interleukin-13 receptor alpha 2

inferred← citeshttps://doi.org/10.1038/s41434-020-00207-9openalex-snapshot

Effects of oncolytic viruses and viral vectors on immunity in glioblastoma

inferred← citeshttps://doi.org/10.1038/s41467-019-10493-6openalex-snapshot

Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma

inferred← citeshttps://doi.org/10.1038/s41467-021-22186-0openalex-snapshot

P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression

inferred← citeshttps://doi.org/10.1038/s41467-023-36878-2openalex-snapshot

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

inferred← citeshttps://doi.org/10.1038/s41467-025-55919-6openalex-snapshot

Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survival

inferred← citeshttps://doi.org/10.1038/s41556-026-01972-2openalex-snapshot

Emerging roles of ferroptosis in modulating the immune landscape of glial tumours

inferred← citeshttps://doi.org/10.1038/s41571-018-0003-5openalex-snapshot

Current state of immunotherapy for glioblastoma

inferred← citeshttps://doi.org/10.1038/s41571-021-00518-9openalex-snapshot

The immune landscape of common CNS malignancies: implications for immunotherapy

inferred← citeshttps://doi.org/10.1038/s41571-022-00679-1openalex-snapshot

Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges

inferred← citeshttps://doi.org/10.1038/s41582-021-00463-2openalex-snapshot

Multifaceted microglia — key players in primary brain tumour heterogeneity

inferred← citeshttps://doi.org/10.1038/s41582-022-00621-0openalex-snapshot

Advances in local therapy for glioblastoma — taking the fight to the tumour

inferred← citeshttps://doi.org/10.1038/s41586-018-0792-9openalex-snapshot

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

inferred← citeshttps://doi.org/10.1038/s41598-019-51063-6openalex-snapshot

Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens

inferred← citeshttps://doi.org/10.1038/s41598-020-65915-zopenalex-snapshot

GATA2 Regulates Constitutive PD-L1 and PD-L2 Expression in Brain Tumors

inferred← citeshttps://doi.org/10.1038/s41598-020-67411-wopenalex-snapshot

GL261 luciferase-expressing cells elicit an anti-tumor immune response: an evaluation of murine glioma models

inferred← citeshttps://doi.org/10.1038/s41598-022-07697-0openalex-snapshot

MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization

inferred← citeshttps://doi.org/10.1038/s41598-025-23412-1openalex-snapshot

Pan-cancer landscape of cellular senescence heterogeneity reveals associations with prognosis and therapy response

inferred← citeshttps://doi.org/10.1038/s41698-018-0070-1openalex-snapshot

Immunogenetics of glioblastoma: the future of personalized patient management

inferred← citeshttps://doi.org/10.1038/s41698-024-00753-0openalex-snapshot

CAR-T cell therapy for the treatment of adult high-grade gliomas

inferred← citeshttps://doi.org/10.1038/s41698-025-00812-0openalex-snapshot

Progress in personalized immunotherapy for patients with brain metastasis

inferred← citeshttps://doi.org/10.1038/s43018-022-00448-0openalex-snapshot

Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity

inferred← citeshttps://doi.org/10.1039/c9ra04590bopenalex-snapshot

Development of cancer immunotherapy based on PD-1/PD-L1 pathway blockade

inferred← citeshttps://doi.org/10.1039/d0nh00446dopenalex-snapshot

Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors

inferred← citeshttps://doi.org/10.1039/d5nr02445eopenalex-snapshot

Nanomotor-mediated drug delivery with efficient blood–brain barrier crossing for active targeting and therapy of glioblastomas: a systematic review

inferred← citeshttps://doi.org/10.1073/pnas.1903542116openalex-snapshot

Glioblastoma ablates pericytes antitumor immune function through aberrant up-regulation of chaperone-mediated autophagy

inferred← citeshttps://doi.org/10.1073/pnas.2521256123openalex-snapshot

Microglial fructose metabolism is essential for glioblastoma growth

inferred← citeshttps://doi.org/10.1080/02656736.2022.2080873openalex-snapshot

Detailed in vitro analyses of the impact of multimodal cancer therapy with hyperthermia and radiotherapy on the immune phenotype of human glioblastoma cells

inferred← citeshttps://doi.org/10.1080/13543784.2020.1768528openalex-snapshot

Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development

inferred← citeshttps://doi.org/10.1080/14712598.2017.1305353openalex-snapshot

Single vs. combination immunotherapeutic strategies for glioma

inferred← citeshttps://doi.org/10.1080/14712598.2018.1531846openalex-snapshot

Promising vaccines for treating glioblastoma

inferred← citeshttps://doi.org/10.1080/14712598.2019.1614557openalex-snapshot

Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinical application

inferred← citeshttps://doi.org/10.1080/14737140.2017.1322903openalex-snapshot

Angiogenesis inhibitors in tackling recurrent glioblastoma

inferred← citeshttps://doi.org/10.1080/14737140.2018.1451749openalex-snapshot

CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing?

inferred← citeshttps://doi.org/10.1080/14737159.2022.2017283openalex-snapshot

Tumor treating fields: a comprehensive overview of the underlying molecular mechanism

inferred← citeshttps://doi.org/10.1080/2162402x.2016.1208876openalex-snapshot

Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma

inferred← citeshttps://doi.org/10.1080/2162402x.2018.1478647openalex-snapshot

Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity

inferred← citeshttps://doi.org/10.1080/2162402x.2021.1902071openalex-snapshot

Integrative analysis identifies an immune-relevant epigenetic signature for prognostication of non-G-CIMP glioblastomas

inferred← citeshttps://doi.org/10.1080/2162402x.2022.2127508openalex-snapshot

AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma

inferred← citeshttps://doi.org/10.1088/1748-605x/ad3abbopenalex-snapshot

Surface engineered nanodiamonds: mechanistic intervention in biomedical applications for diagnosis and treatment of cancer

inferred← citeshttps://doi.org/10.1093/braincomms/fcad176openalex-snapshot

Clinical impact of anti-inflammatory microglia and macrophage phenotypes at glioblastoma margins

inferred← citeshttps://doi.org/10.1093/jnci/djy107openalex-snapshot

The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma

inferred← citeshttps://doi.org/10.1093/jnen/nlab041openalex-snapshot

Expression and Prognostic Value of the Immune Checkpoints Galectin-9 and PD-L1 in Glioblastomas

inferred← citeshttps://doi.org/10.1093/jnen/nlz120openalex-snapshot

Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes

inferred← citeshttps://doi.org/10.1093/narcan/zcaa011openalex-snapshot

Mechanistic models of signaling pathways deconvolute the glioblastoma single-cell functional landscape

inferred← citeshttps://doi.org/10.1093/neuonc/noaa277openalex-snapshot

Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank

inferred← citeshttps://doi.org/10.1093/neuonc/noae203openalex-snapshot

Chimeric antigen receptor T-cell therapy in patients with malignant glioma—From neuroimmunology to clinical trial design considerations

inferred← citeshttps://doi.org/10.1093/neuonc/noaf106openalex-snapshot

Dual aVß8 Integrin and PD-1 Blockade Overcomes TGFβ-Mediated B-Cell Suppression to Enhance Anti-Tumor Immunity

inferred← citeshttps://doi.org/10.1093/neuonc/noag073openalex-snapshot

Exploring the immune environment of glioblastoma in humanized mouse models

inferred← citeshttps://doi.org/10.1093/neuonc/nox139openalex-snapshot

Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma

inferred← citeshttps://doi.org/10.1093/neuonc/noy145openalex-snapshot

Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy

inferred← citeshttps://doi.org/10.1093/neuros/nyaa421openalex-snapshot

Radiotherapy, Temozolomide, and Antiprogrammed Cell Death Protein 1 Treatments Modulate the Immune Microenvironment in Experimental High-Grade Glioma

inferred← citeshttps://doi.org/10.1093/neuros/nyy268openalex-snapshot

Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype Glioblastoma

inferred← citeshttps://doi.org/10.1093/neuros/nyy392openalex-snapshot

Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade

inferred← citeshttps://doi.org/10.1093/neuros/nyz167openalex-snapshot

Missing Naïve T Cells in the Setting of Glioblastoma Are Found to Be Sequestered in the Bone Marrow

inferred← citeshttps://doi.org/10.1093/noajnl/vdac104openalex-snapshot

Safety of intra-arterial chemotherapy with or without osmotic blood–brain barrier disruption for the treatment of patients with brain tumors

inferred← citeshttps://doi.org/10.1093/noajnl/vdad044openalex-snapshot

Convection-enhanced delivery of immunomodulatory therapy for high-grade glioma

inferred← citeshttps://doi.org/10.1093/noajnl/vdae204openalex-snapshot

The glioma microenvironment and its impact on antitumor immunity

inferred← citeshttps://doi.org/10.1093/noajnl/vdaf118openalex-snapshot

Current landscape of immunotherapy for CNS tumors

inferred← citeshttps://doi.org/10.1093/noajnl/vdz053openalex-snapshot

Longitudinal evolution of the immune suppressive glioma microenvironment in different synchronous lesions during treatment

inferred← citeshttps://doi.org/10.1093/nop/npab026openalex-snapshot

Tumor-Treating Fields for the treatment of glioblastoma: a systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1097/cm9.0000000000004009openalex-snapshot

Chemokine–chemokine receptor axis: Emerging immunotherapeutic paradigms for solid tumor microenvironment reprogramming

inferred← citeshttps://doi.org/10.1097/coc.0000000000000406openalex-snapshot

Radiation and Immunotherapy in High-grade Gliomas

inferred← citeshttps://doi.org/10.1101/2020.03.30.016667openalex-snapshot

Inhibition of the αv integrin-TGF-β axis improves natural killer cell function against glioblastoma stem cells

inferred← citeshttps://doi.org/10.1101/2020.10.07.330043openalex-snapshot

Tumor-responsive, multifunctional CAR-NK cells cooperate with impaired autophagy to infiltrate and target glioblastoma

inferred← citeshttps://doi.org/10.1101/2023.12.08.23299733openalex-snapshot

Revealing the biology behind MRI signatures in high grade glioma

inferred← citeshttps://doi.org/10.1101/2024.12.28.628031openalex-snapshot

Inhibition of the extracellular matrix protein fibulin-3 reduces immunosuppressive signaling in tumor stem cells and increases macrophage activation against glioblastoma

inferred← citeshttps://doi.org/10.1101/2025.03.09.642289openalex-snapshot

Targeting CHEK2-YBX1&YBX3 regulatory hub to potentiate immune checkpoint blockade response in gliomas

inferred← citeshttps://doi.org/10.1101/2025.08.08.669313openalex-snapshot

Rationally Engineered Coronavirus-mimicking Protein Nanocage Platform for Glioblastoma Targeted Delivery and Immunity Regulation

inferred← citeshttps://doi.org/10.1111/cas.70218openalex-snapshot

COL6A2 : A Key Survival‐Related Gene and Restricting Antitumor Immunity in Glioblastoma

inferred← citeshttps://doi.org/10.1111/cns.13714openalex-snapshot

Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma

inferred← citeshttps://doi.org/10.1111/cns.14495openalex-snapshot

Oligomer‐Aβ42 suppress glioma progression via potentiating phagocytosis of microglia

inferred← citeshttps://doi.org/10.1111/imm.13517openalex-snapshot

Update on the current knowledge of lymphatic drainage system and its emerging roles in glioma management

inferred← citeshttps://doi.org/10.1126/scisignal.adk3320openalex-snapshot

A lupus-derived autoantibody that binds to intracellular RNA activates cGAS-mediated tumor immunity and can deliver RNA into cells

inferred← citeshttps://doi.org/10.1126/scitranslmed.aaw5680openalex-snapshot

Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial

inferred← citeshttps://doi.org/10.1126/scitranslmed.aeg8772openalex-snapshot

Glioblastoma: Overcoming fundamental biological and delivery barriers to therapy

inferred← citeshttps://doi.org/10.1136/bcr-2018-227500openalex-snapshot

Cerebral aspergillosis within new tumour site presents as incidental new brain lesion in patient receiving temozolomide for glioblastoma multiforme

inferred← citeshttps://doi.org/10.1136/jitc-2019-000348openalex-snapshot

Biomarkers for immunotherapy for treatment of glioblastoma

inferred← citeshttps://doi.org/10.1146/annurev-med-042420-102102openalex-snapshot

New Approaches to Glioblastoma

showing the first 200 of 356

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.